Press Releases

2019 Healthcare Nanotechnology (Nanomedicine) Market Future Growth Rate by Market Current Strategy, Top Most Players, and Regional Segmentation by Forecast to 2024

May 17, 2019

Healthcare Nanotechnology (Nanomedicine)

The Prime objective of “Healthcare Nanotechnology (Nanomedicine) Market” report is to provides an in-depth analysis of all market dynamics including drivers and restraints, and trends and opportunities. Important factors supporting growth across various is also provided. Using the industrial figures, the market finds growth figures between the forecast period from 2019 to 2024. In order to present an executive-level model of the market and its future perspectives, the report presents a clear segmentation based on different parameters. The factors that affect these segments are also discussed in detail in the report.

Request For Sample Copy of Healthcare Nanotechnology (Nanomedicine) Market Report @ https://www.industryresearch.co/enquiry/request-sample/14099195

Top Key Players Are:

  • Sanofi SA
  • Celegene Corporation
  • CytImmune Sciences Inc.
  • Johnson & Johnson
  • Luminex Corporation
  • Merck & Co. Inc.
  • Nanobiotix
  • Pfizer Inc.
  • Starpharma Holdings Limited
  • Taiwan Liposome Company Ltd

    Healthcare Nanotechnology (Nanomedicine) Market Report Covers the Top Regions:

    United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, GCC, South Africa, Brazil, Argentina.

    Scope of Healthcare Nanotechnology (Nanomedicine) Market:

    As per the , the healthcare nanotechnology (nanomedicine) market includes products that are nanoformulations of the existing drugs or new drugs or are nanobiomaterials. The market is segmented by its application in the medical field, as drug delivery, biomaterials, active implants, diagnostic imaging, tissue regeneration, and other applications. The market is also segmented by its use in the treatment of diseases, like cardiovascular diseases, oncological diseases, neurological diseases, orthopedic diseases, infectious diseases, and other diseases.

    Have Any Query, Ask Our Industry Experts @ https://www.industryresearch.co/enquiry/pre-order-enquiry/14099195

    Key Market Trends:

    The Growth of Nanomedicine is Expected to Provide High Opportunities for the Treatment of Neurological Diseases, Over the Forecast Period

    A large number of brain disorders with neurological and psychological conditions result in short-term and long-term disabilities. Recent years observed a significant number of research studies being published on methods for the synthesis of nanoparticle-encapsulated drugs within in vivo and in vitro studies. The insufficient absorbance of oral drugs administered for a range of neurological conditions, such as Alzheimer’s disease, Parkinson disease, tumor, neuro-AIDS, among others, opens up the necessity of nanomedicine with stem cell therapy. Some of the registered nanoparticles for the complex CNS treatment are a gold nanoparticle, lipid nanoparticle, and chitosan nanoparticles.

    Other than neurological diseases, research-based progress was found in the treatment of cancers, with the scientific communities identifying new metabolic pathways to find better drug combination using nanomedicine.

    North America is Expected to Hold the Largest Share in the Market

    In the United States, several companies are closely observing the developments in nanostructured materials across various applications in the healthcare industry, including medical devices, to improve efficiency and efficacy. In the United States, the National Nanotechnology Initiative (NNI), which was initiated in 2000, is among the supreme bodies that manage all nanotechnology-related activities. Under the NNI, several agencies are working in collaboration with companies and universities. For instance, nano-manufacturing in Small Business Innovation Research (SBIR) programs were developed for both commercial and public use. Companies are targeting the treatment of several cancer types and infectious diseases through immunotherapy, where nanoemulsion vaccines and drugs play a significant role. In the United States, one of the major challenges associated with nanotechnology is the ability to integrate nanoscale materials into new devices and systems, along with an application of novel properties at the nano-level. Thus, most of the companies are investing in R&D. Nanotechnology is likely to play a significant role in the delivery of drugs. In the recent strategic plan presented by the NNI in 2016, several programs were identified to further advance the research and development programs, over the forecast period.

    Report Highlights:

    • Market Dynamics – Drivers, Restraints, and Opportunities
    • Market Segmentation – Types, Applications, Regions, and Technology
    • Market Trends
    • Competitive Landscape
    • SWOT Analysis and Porter’s Five Forces Analysis

    Purchase Healthcare Nanotechnology (Nanomedicine) Market Report @ https://www.industryresearch.co/purchase/14099195

    Price of Report: $ 4250 (SUL)

    Detailed TOC of Healthcare Nanotechnology (Nanomedicine) Market Research Report 2019 – 2024:

    1 INTRODUCTION
    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study

    2 RESEARCH METHODOLOGY

    3 EXECUTIVE SUMMARY

    4 MARKET DYNAMICS
    4.1 Market Overview
    4.2 Market Drivers
    4.2.1 Growing Prevalence of Cancer and Genetic and Cardiovascular Diseases
    4.2.2 Increasing Advancements in Nanoscale Technologies for Diagnostic Procedures
    4.2.3 Growing Preference for Personalized Medicines
    4.3 Market Restraints
    4.3.1 High Cost
    4.3.2 Stringent Regulations for Commercial Introduction
    4.4 Porter’s Five Forces Analysis
    4.4.1 Threat of New Entrants
    4.4.2 Bargaining Power of Buyers/Consumers
    4.4.3 Bargaining Power of Suppliers
    4.4.4 Threat of Substitute Products
    4.4.5 Intensity of Competitive Rivalry

    5 MARKET SEGMENTATION
    5.1 By Application
    5.1.1 Drug Delivery
    5.1.2 Biomaterials
    5.1.3 Active Implants
    5.1.4 Diagnostic Imaging
    5.1.5 Tissue Regeneration
    5.1.6 Other Applications
    5.2 By Disease
    5.2.1 Cardiovascular Diseases
    5.2.2 Oncological Diseases
    5.2.3 Neurological Diseases
    5.2.4 Orthopedic Diseases
    5.2.5 Infectious Diseases
    5.2.6 Other Diseases
    5.3 Geography
    5.3.1 North America
    5.3.1.1 US
    5.3.1.2 Canada
    5.3.1.3 Mexico
    5.3.2 Europe
    5.3.2.1 France
    5.3.2.2 Germany
    5.3.2.3 UK
    5.3.2.4 Italy
    5.3.2.5 Spain
    5.3.2.6 Rest of Europe
    5.3.3 Asia-Pacific
    5.3.3.1 China
    5.3.3.2 Japan
    5.3.3.3 India
    5.3.3.4 Australia
    5.3.3.5 South Korea
    5.3.3.6 Rest of Asia-Pacific
    5.3.4 Middle East & Africa
    5.3.4.1 GCC
    5.3.4.2 South Africa
    5.3.4.3 Rest of Middle East & Africa
    5.3.5 South America
    5.3.5.1 Brazil
    5.3.5.2 Argentina
    5.3.5.3 Rest of South America

    6 COMPETITIVE LANDSCAPE
    6.1 Company Profiles
    6.1.1 Sanofi SA
    6.1.2 Celegene Corporation
    6.1.3 CytImmune Sciences Inc.
    6.1.4 Johnson & Johnson
    6.1.5 Luminex Corporation
    6.1.6 Merck & Co. Inc.
    6.1.7 Nanobiotix
    6.1.8 Pfizer Inc.
    6.1.9 Starpharma Holdings Limited
    6.1.10 Taiwan Liposome Company Ltd

    7 MARKET OPPORTUNITIES AND FUTURE TRENDS

    About Industry Research:

    Industry Research is an upscale platform to help key personnel in the business world in strategizing and taking visionary decisions based on facts and figures derived from in-depth market research. We are one of the top report resellers in the market, dedicated to bringing you an ingenious concoction of data parameters.

    Contact Us:

    Name: Ajay More

    Organization: Industry Research

    Phone: +44 20 3239 8187 / +14242530807

    Email: [email protected]

    Our latest Report: Drinking Water Market 2019 Offers Newest Industry Data, Industry Future Trends, Sales, Revenue, Growth Rate by Types and Applications Forecast till 2023